EGFR and glioblastoma: Although the presented data are not sufficient to question the indications for radiotherapy for glioblastoma patients with EGFR amplification and require validation in a larger group of patients, they strongly advocate for the consideration of the patient’s molecular status in the putative selection of the therapy, especially in the light of the numerous novel therapeutic possibilities being introduced.